RecallRadar

FDA Drug recall D-0007-2017

buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, Twice-A-Day, in 60 count bottles, Rx only, Distributed by: Sun Pharmace…

On 2016-10-12 the FDA classified a Class III recall of buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, Twice-A-Day, in 60 count bottles, Rx only, Distributed by: Sun Pharmace… by Sun Pharmaceutical Industries, citing failed Dissolution Specifications.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0007-2017
ClassificationClass III
Statusterminated
Initiated2016-09-13
Published2016-10-12
Last updated2026-09-13 11:51 UTC
CompanySun Pharmaceutical Industries
DistributionUS

Product

buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, Twice-A-Day, in 60 count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by Sun Pharmaceuticals Ind. Ltd. Halol- Baroda Highway, Halol-389 350, Gujarat, India. UPC 347335737868 NDC 47335-737-86

Reason

Failed Dissolution Specifications

Identifiers

upc347335737868
ndc47335-736-86
ndc47335-736-88
ndc47335-736-08
ndc47335-736-13
ndc47335-737-86
ndc47335-737-88
ndc47335-737-08
ndc47335-737-13
ndc47335-738-86
ndc47335-738-88
ndc47335-738-08
ndc47335-738-13
ndc3473357378
code_infoJKN5124A and JKN5229A, exp 10/2016

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0007-2017%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.